Sara Putnam
Podiatrist · Stoneham, MANPI 1477014546
Payments from drug & device makers
What this record shows
This record is dominated by education: $1,200 of the $1,629 with a category attached, or 73.7%. Medwest Associates accounts for 74.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $1,218 and has fallen 95.1% since, to $60 in 2025.
Across 17 payments — averaging $95.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medwest Associates$1K
- Stryker$231
- Johnson & Johnson$52
- Smith+Nephew$47
- Bioventus LLC$37
- Treace Medical Concepts, Inc.$22
- plus $21 from 1 others
What the payments were for
- Food & beverage$42926%
- Education$1,20074%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medwest Associates | 2 | $1,218 |
| Stryker | 6 | $231 |
| Johnson & Johnson | 2 | $52 |
| Smith+Nephew | 3 | $47 |
| Bioventus LLC | 2 | $37 |
| Treace Medical Concepts, Inc. | 1 | $22 |
| Medline Industries LP | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,629 in reported general payments places this provider in the 70th percentile of 179 podiatrist providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 35 | $851 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 26 | $670 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $168 |
| Methylprednisolone | 11 | $59 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Stoneham
- Pasquale CancelliereSomerville$374K
- Michael TheodoulouSomerville$210K
- Sara Rose-SauldWaltham$92K
- Jonathan KaplanWellesley$56K
- Thanh DinhBoston$48K
- Melissa RicciMilton$46K
- Jeffrey PantanoMilton$46K
- Barry RosenblumBoston$43K
- Louis DecaroWest Hatfield$19K
- Daren BergmanFramingham$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.